Accounts Receivable, after Allowance for Credit Loss, Current in USD of Autolus Therapeutics plc from Q4 2021 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
Autolus Therapeutics plc quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2021 to Q4 2024.
- Autolus Therapeutics plc Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2024 was $15K, a 86.2% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)